mRNA-based therapeutics — developing a new class of drugs

Uğur Şahin; Katalin Karikó; Özlem Türeci

doi:10.1038/nrd4278

mRNA-based therapeutics — developing a new class of drugs

Uğur Şahin(University Medical Center of the Johannes Gutenberg University Mainz), Katalin Karikó(BioNTech (Germany)), Özlem Türeci(University Medical Center of the Johannes Gutenberg University Mainz)

Nature Reviews Drug Discovery

September 19, 2014

10.1038/nrd4278

Cited by 2,393Open Access

Full Text

Abstract

E. Neumann, Maria Schaefer-Ridder, Y. Wang et al.|The EMBO Journal|1982|2.5k

Janeway's Immunobiology

Kenneth Murphy, Casey T. Weaver|W.W. Norton & Company eBooks|2016|2.3k

Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins

Kazuhisa Nakayama|Biochemical Journal|1997|788

Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer

Zhen Su, Jens Dannull, Benjamin Yang et al.|The Journal of Immunology|2005|365

Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

SA Martin, Enzo Paoletti, Bernard Moss|Journal of Biological Chemistry|1975|356

mRNA-based therapeutics — developing a new class of drugs

Abstract

Related Papers